Hub

China healthcare system hub

China’s healthcare system needs to be understood as an internal institutional system, not merely as a market opportunity.

1Start with structureRead the overview before specialized pages.
2Use comparisons carefullySimilar words often describe different institutions.
3Verify live rulesRegulatory and payment details should be checked against primary sources.
4Follow the pathwayMove from system structure to the specific payer, regulator, provider, or market-access question.
Core pages

Recommended starting points

These pages orient the reader before moving into specialized topics such as hospitals, insurance, reimbursement, regulation, public health, medtech, biopharma, digital health, and market entry.

Payment and procurement reform layer

Payment, procurement, pricing, and incentive pages

These pages explain how China uses procurement, reimbursement, service pricing, payment reform, and compliance pressure to change healthcare economics.

Volume-Based Procurement in Chinaprocurement and price-control policy instrument Drug Volume-Based Procurement in Chinadrug procurement and price-volume tradeoff Medical Device Volume-Based Procurement in Chinadevice and consumables procurement reform High-Value Medical Consumables Procurement in Chinamedtech-specific procurement pathway National Drug Price Negotiations in ChinaNRDL-linked drug pricing mechanism NRDL Negotiation Strategy for Drug Companiescompany playbook for NRDL access Zero Markup Drug Policy in Chinapublic hospital revenue reform Public Hospital Compensation Reform in Chinapublic hospital incentive and revenue redesign DRG Payment in Chinadiagnosis-related group payment reform DIP Payment Reform in ChinaBig Data Diagnosis-Intervention Packet reform Global Budgets in Chinese Healthcarepayer budget constraint Capitation Pilots in Chinapopulation-based payment experiment Fee-for-Service in Chinapayment method and reform target Essential Medicines in Chinaprimary-care and medicine policy term Centralized Procurement in Chinese Healthcarecentralized purchasing architecture beyond VBP Two-Invoice System in Chinapharmaceutical distribution reform Medical Price Controls in Chinapricing administration across products and services Medical Service Pricing Reform in Chinaservice price reform in public hospitals Provider Incentives in Chinese Hospitalsincentive map around hospitals and physicians Healthcare Anti-Corruption Campaigns in Chinagovernance and procurement risk issue
History and TCM layer

History, public health, and Traditional Chinese Medicine pages

These pages explain Chinese medical history, reform eras, public-health shocks, TCM institutions, regulation, exports, and scientific debate.

U.S.-China comparison layer

Researched U.S.-China comparison pages

These pages compare the institutional mechanisms that drive access, payment, provider behavior, technology adoption, and regulation in the two systems.

U.S. vs. China Healthcare Systemsystem architecture comparison U.S. vs. China Health Insuranceinsurance architecture and financial protection comparison U.S. vs. China Hospitalshospital role, ownership, hierarchy, and patient behavior U.S. vs. China Primary Caregatekeeping, community care, and first-contact access U.S. vs. China Rural Healthcarerural access with different institutional causes U.S. vs. China Urban Healthcareurban concentration and navigation problem U.S. vs. China Public Healthpublic-health administration and state capacity U.S. vs. China Aging and Healthcareaging pressure, family structure, and financing U.S. vs. China Long-Term Carelong-term care financing and delivery U.S. vs. China Physician Workforcetraining, compensation, status, and practice environment U.S. vs. China Nursing Workforcenursing supply, role, and staffing context U.S. vs. China Medical Educationmedical training, licensing, and career pathway U.S. vs. China Hospital PaymentDRGs, FFS, budgets, payer contracts, and incentives U.S. vs. China Drug PricingPBMs, Medicare, NRDL, VBP, and negotiation U.S. vs. China Medical Device Pricinghospital purchasing, GPOs, VBP, and value analysis U.S. vs. China Reimbursementpayment pathways for products and services U.S. vs. China Health Technologyadoption environment for digital health and medtech U.S. vs. China Telehealthtelehealth regulation, payment, and adoption patterns U.S. vs. China Healthcare Data PrivacyHIPAA versus PIPL and data-security context U.S. vs. China AI Governance in Healthcaremedical AI regulation, data governance, and adoption
Governance and stakeholder layer

China healthcare agencies, laws, professional bodies, and stakeholder map

These pages explain agency roles, implementation authority, data laws, anti-corruption governance, professional regulation, medical education, HTA, and the larger Chinese healthcare stakeholder map.

Provider market and service-line layer

China provider markets, private care, service lines, and supplemental channels

These pages analyze public hospital reform, private and international care, hospital groups, checkups, rehabilitation, mental health, major service lines, commercial insurance, and employer health benefits.